US Stock MarketDetailed Quotes
XFOR X4 Pharmaceuticals
- 0.338
- -0.030-8.25%
Close Nov 22 16:00 ET
- 0.347
- +0.009+2.66%
Post 20:01 ET
57.64MMarket Cap-4225P/E (TTM)
0.368High0.333Low2.60MVolume0.368Open0.368Pre Close886.81KTurnover2.00%Turnover RatioLossP/E (Static)170.55MShares1.60052wk High0.97P/B43.91MFloat Cap0.26152wk Low--Dividend TTM129.91MShs Float23.930Historical High--Div YieldTTM9.34%Amplitude0.261Historical Low0.340Avg Price1Lot Size
About X4 Pharmaceuticals Company
X4 Pharmaceuticals, Inc. is a late clinical-stage company, which engages in the development and discovery of novel therapeutics for the treatment of rare diseases and those with limited treatment options. Its clinical candidate is mavorixafor. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan in 2010 and is headquartered in Boston, MA.
Company Profile
SymbolXFOR
Company NameX4 Pharmaceuticals
Listing DateNov 16, 2017
Issue Price10.00
Founded2010
CEODr. Paula S. Ragan, PhD
MarketNASDAQ
Employees93
Fiscal Year Ends12-31
Address61 North Beacon Street,4th floor
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02134
Phone1-857-529-8300
Websitehttp://www.x4pharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Paula S. Ragan, PhD
- Director, President and Chief Executive Officer
- 2.04M
- Arthur Taveras
- Chief Scientific Officer
- --
- Dr. Mary DiBiase, PhD
- Chief Operating Officer
- --
- Mark Baldy
- Chief Commercial Officer
- --
- Adam S. Mostafa
- Chief Financial Officer, Principal Accounting Officer, Treasurer and Corporate Secretary
- 1.15M
- Christophe Arbet-Engels
- Chief Medical Officer
- 1.64M
- Michael Stephen Wyzga
- Chairman of the Board
- 199.34K
- Dr. Gary J. Bridger, PhD
- Director
- 147.05K
- Dr. Murray W. Stewart, M.D.
- Director
- 90.08K
- David W.J. McGirr, M.B.A.
- Independent Director
- 166.05K
- Francoise de Craecker
- Independent Director
- 152.05K
- William E. Aliski
- Independent Director
- 165.05K
- Alison F. Lawton
- Independent Director
- 154.55K
- Robert Keith Woods
- Independent Director
- 91.83K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data